![Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders](https://www.frontiersin.org/files/MyHome%20Article%20Library/963691/963691_Thumb_400.jpg)
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
![Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep33401/MediaObjects/41598_2016_Article_BFsrep33401_Fig1_HTML.jpg)
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
![Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety | Neuropsychopharmacology Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-020-0725-9/MediaObjects/41386_2020_725_Fig1_HTML.png)
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety | Neuropsychopharmacology
![Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41380-018-0117-2/MediaObjects/41380_2018_117_Fig1_HTML.jpg)
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
![A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/62c8920a6383266dc946ad00/largeThumb/a-systematic-review-on-the-kappa-opioid-receptor-and-its-ligands-new-directions-for-the-treatment-of-pain-anxiety-depression-and-drug-abuse.jpg)
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Figure 4 | A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink Figure 4 | A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig4_HTML.png)
Figure 4 | A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
![Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System](https://www.frontiersin.org/files/Articles/856672/fphar-13-856672-HTML/image_m/fphar-13-856672-g001.jpg)
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
![Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763419306323-gr5.jpg)
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
![Researchers identify possible therapeutic target for depression and addiction - The Source - Washington University in St. Louis Researchers identify possible therapeutic target for depression and addiction - The Source - Washington University in St. Louis](https://news.wustl.edu/news/PublishingImages/Neuron%20preview%203%20crop_primary.jpg)
Researchers identify possible therapeutic target for depression and addiction - The Source - Washington University in St. Louis
![Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763419306323-gr1.jpg)
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
![Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763419306323-gr3.jpg)
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
![Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.9b00195/asset/images/large/cn-2019-00195v_0008.jpeg)